Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT06189963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/IIa, Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Moderate Alzheimer's Disease
Study identification
- NCT ID
- NCT06189963
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- NKGen Biotech, Inc.
- Industry
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Interventions
- Placebo Other
- SNK01 Biological
Other · Biological
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 20, 2023
- Primary completion
- Nov 30, 2026
- Completion
- May 31, 2027
- Last update posted
- May 13, 2026
2023 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Behavioral Research Specialists, LLC | Glendale | California | 91206 | Recruiting |
| Syrentis Clinical Research | Santa Ana | California | 92705 | Recruiting |
| Valiance Clinical Research | Tarzana | California | 91356 | Withdrawn |
| K2 Medical Research | Maitland | Florida | 32751 | Not yet recruiting |
| AdventHealth Research Institute | Orlando | Florida | 32804 | Recruiting |
| Rutgers Health | Newark | New Jersey | 07107 | Not yet recruiting |
| Alzheimer's Disease Research Center | Albany | New York | 12208 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06189963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06189963 live on ClinicalTrials.gov.